Real Brands (RLBD) Completes Acquisition of CBD Pharmacy

Share

(NEW YORK)–Real Brands, Inc. (OTCMKTS:RLBD), a consumer beverage company within the cannabis industry, completes its acquisition of CBD Pharmacy.

In filing with OTC Markets, the Company announced it has completed its acquisition of CBD Pharmacy, which now gives RLBD an operating and revenue generating entity within the cannabis CBD market.

Under the deal, the Company now owns the CBD Pharmacy™ trademark, plus four (4) US utility patents for the manufacturer of consumable legal cannabis and hemp products as defined by the states on a state by state basis. In addition RLBD has also agreed to acquire four (4) Colorado trademarks for use in legal cannabis and hemp products.

In past statement Jerry Pearring, the CEO of Real Brands, Inc. commented, “The acquisition of the CBD Pharmacy™ trademark, as well as the rest of this IP, will be a catalyst in RLBD’s strategy to build successful brands in this rapidly expanding industry. As a brand building company, we believe that the strong positioning of these trademarks, as well as these unique and protected formulas, will present RLBD immediate opportunities to grow through licensing and new product development in California, Colorado and Washington.”

The acquisition of ‘CBD Pharmacy’ now opens the door not just for RLBD to market their own brand of cannabis related products, such as their Omega Hemp Water line, but could also become a centralized hub where other cannabis companies could market their medical products as a major CBD ecommerce platform.

Research Upgrade

Ludlow Research, a smallcap equity research firm based in New York City, reiterated their coverage on RLBD based on their recent acquisitions, and low market cap valuation, with a short-term valuation target on RLBD of $0.15+ per share.

Real Brands, Inc. is traded on the OTC market under the ticker symbol “RLBD”.

About Real Brands

Real Brands, Inc. (RLBD) is a publicly held company. The Company’s strategy is to build brands and is currently focusing on consumer products brand development and marketing in the legal hemp and cannabis industry. Real Brands, Inc. currently has a super majority controlling equity interest in Omega Hemp Water trademarks and intellectual properties. For additional information go to www.realbrandsusa.com

 


Disclaimer:
This is NOT a solicitation to Buy or Sell any security, but rather is for informational purposes only. Content contained herein includes facts, views, opinions and recommendations of individuals and organizations deemed of interest. Wall Street Newscast (“WSNC”) does not guarantee the accuracy, completeness or timeliness of, or otherwise endorse these views, opinions or recommendations, or give investment advice. WSNC, its affiliates, or directors, may or may not hold a position in the above security from time to time, and investors are encourage to consider this as a possible conflict of interest when reviewing this information. In Compliance with SEC Rule 17B Wall Street Newscast was not compensated for ongoing media advisory services, and thus should be considered a possible conflict of interest when reviewing this report and information. WSNC, or its affiliates, may hold a position in above securities from time to time, and thus should be considered a possible conflict of interest when reviewing this report and information. These investments may involve a high degree of risk, thus investors are highly encouraged to consult with a financial advisor before any and all investments.

Safe Harbor Statements:
This website includes statements that may constitute forward-looking statements made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Although the Company believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions, such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected.

High Risk
Small and Micro cap, or ‘penny stocks’, involve a high degree of risk, and we highly encourage investors to consult with a financial advisor before making any and all investment decisions when investing in these type of securities.